307011000036101: vial (AU qualifier)
Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Expanded Value Set
Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Oxaliplatin (AS) (oxaliplatin 100 mg) powder for injection, 1 x 100 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Oxaliplatin (AS) 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fludarabine (AS) 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Docetaxel (Accord) 160 mg/8 mL injection, 8 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Immucyst 81 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Riximyo 500 mg/50 mL injection, 2 x 50 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Riximyo 100 mg/10 mL injection, 2 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Riximyo 500 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Riximyo (rituximab 100 mg / 10 mL) injection, 3 x 10 mL vials (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ocrevus 300 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Start Previous Page 29 of 29
Reference Sets
Medication container type reference set
Back to Start